Sign in

Jay Laver

@jaylaver.bsky.social
20 followers 18 following 0 posts

Principal Investigator in Controlled Human Infection at the University of Southampton. Board game enthusiast and general nerd.

PostsRepliesMedia
Reposted by Jay Laver
Dr Anastasia Theodosiou @doctoranastasia.bsky.social · 01/04/2025
🔥🔥 Not an April Fool: my paper is on the *front cover* of @lancetmicrobe.bsky.social! 🤯🤯 New issue live today 🎉 Just look at that gorgeous diplococcus 😍🧫🦠👩‍🔬 Endless thanks to Chrissie Jones, Rob Read, @dbogaert.bsky.social @adamdale.bsky.social @jaylaver.bsky.social @bacterioskeptic.bsky.social
0125
Reposted by Jay Laver
Michael Marks @drmichaelmarks.bsky.social · 19/12/2024
Delighted to see our work with @who.int DRC MoH & @lshtm.bsky.social out @nejm.org Performed largest ever evaluation rVSV-ZEBOV-GP for Ebola during 2018-20 outbreak. In >200,000 individuals showed vaccine safe & offers significant protection. They now represent cornerstone of response to Ebola.
nejm.org
Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination | NEJM
At the beginning of the 2018–2020 outbreak of Ebola virus disease (EVD) in eastern Democratic Republic of Congo (DRC), no vaccine had been licensed. However, cluster-randomized evidence from Guinea...
3389
Reposted by Jay Laver
Clinical Infectious Diseases @cidjournal.bsky.social · 19/12/2024
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season ✅ Just Accepted #IDSky
buff.ly
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season
We hypothesized that response to infant pneumococcal conjugate vaccines (PCVs), administered during peak respiratory viral seasons could be blunted, particularly to higher carrier-load PCVs.
122
Reposted by Jay Laver
Adam Dale @adamdale.bsky.social · 29/11/2024
@hicvac.bsky.social with Southampton Controlled Human Infection Group. Fantastic poster presentation by @alihill.bsky.social outlining T cell responses induced by the novel pertussis vaccine candidate, BPZE1 👏
162
Reposted by Jay Laver
Alison Hill @alihill.bsky.social · 29/11/2024
Fantastic view of Liverpool from the @hicvac.bsky.social conference venue. Looking forward to another day of talks today!
032